In this subchapter:
(1) "Contraindication" means the potential for, or the occurrence of:
- (A) an undesirable change in the therapeutic effect of a prescribed drug because of the presence of a disease condition in the patient for whom the drug is prescribed; or
- (B) a clinically significant adverse effect of a prescribed drug on a disease condition of the patient for whom the drug is prescribed.
- (2) "Drug" has the meaning assigned by Section 551.003, Occupations Code.
- (2-a) "Enrollee" means an individual who is covered under a health benefit plan, including a covered dependent.
- (3) "Indication" means a symptom, cause, or occurrence in a disease that points out the cause, diagnosis, course of treatment, or prognosis of the disease.
- (4) "Peer-reviewed medical literature" means scientific studies published in a peer-reviewed national professional journal.
Added by Acts 2003, 78th Leg., ch. 1274, Sec. 3, eff. April 1, 2005.
Acts 2017, 85th Leg., R.S., Ch. 727 (S.B. 1076), Sec. 1, eff. September 1, 2017.